Patient capital. Hands-on incubation. End-to-end translation.
Australia generates world-class biomedical research, yet too often that innovation stalls between the lab and the market. Proto Axiom exists to close that gap. We combine institutional capital with deep scientific diligence, experienced company-building and a global advisory network to turn early-stage discoveries into funded, governed, investment-ready companies.
Discover our investment process
.png)
.png)
